Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-23 Purchase |
2021-06-25 09:00 am |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
20,710 | $9.2827 | $192,245 | 1,962,221 (Indirect) |
View |
| 2021-06-21 Purchase |
2021-06-23 08:33 am |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
47,274 | $8.9354 | $422,414 | 1,941,511 (Indirect) |
View |
| 2021-06-08 Purchase |
2021-06-10 09:00 am |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
16,605 | $9.4977 | $157,709 | 1,894,237 (Indirect) |
View |
| 2021-06-03 Purchase |
2021-06-07 08:53 am |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
12,357 | $9.2551 | $114,365 | 1,877,632 (Indirect) |
View |
| 2021-05-28 Purchase |
2021-06-02 10:37 am |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
14 | $9.5 | $133 | 1,865,275 (Indirect) |
View |
| 2021-05-26 Purchase |
2021-05-28 4:10 pm |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
7,035 | $9.3624 | $65,864 | 1,865,261 (Indirect) |
View |
| 2021-04-13 Purchase |
2021-04-15 6:16 pm |
Reneo Pharmaceuticals Inc. | RPHM | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Florence Anthony A. Jr. Makhzoumi Mohamad MAKOWER JOSHUA SANDELL SCOTT D Sonsini Peter W. 10% Owner |
666,666 | $15 | $9,999,990 | 4,785,494 (Direct) |
View |
| 2021-04-13 Purchase |
2021-04-15 4:16 pm |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
200,000 | $15 | $3,000,000 | 2,063,713 (Indirect) |
View |
| 2021-04-13 Purchase |
2021-04-15 4:15 pm |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
200,000 | $15 | $3,000,000 | 1,858,226 (Indirect) |
View |
| 2021-04-13 Purchase |
2021-04-14 4:44 pm |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
666,666 | $15 | $9,999,990 | 3,430,377 (Direct) |
View |
| 2021-04-09 Purchase |
2021-04-13 5:54 pm |
Reneo Pharmaceuticals Inc. | RPHM | RiverVest Venture Fund III L.P. RiverVest Venture Fund III (Ohio) L.P. RiverVest Venture Fund IV L.P. 10% Owner |
200,000 | $15 | $3,000,000 | 2,409,220 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-13 Conversion |
2021-04-15 6:16 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Florence Anthony A. Jr. Makhzoumi Mohamad MAKOWER JOSHUA SANDELL SCOTT D Sonsini Peter W. 10% Owner |
22,549,760 | $0 | 4,785,494 (Direct) |
View |
| 2021-04-13 Conversion |
2021-04-15 4:16 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
10,203,459 | $0 | 2,063,713 (Indirect) |
View |
| 2021-04-13 Conversion |
2021-04-15 4:15 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
9,078,458 | $0 | 1,858,226 (Indirect) |
View |
Ownership(A) |
2021-04-15 4:12 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
0 | $0 | 424,600 (Indirect) |
View |
| 2021-04-13 Conversion |
2021-04-15 4:10 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
110,384 | $0 | 578,846 (Indirect) |
View |
| 2021-04-13 Conversion |
2021-04-14 4:44 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
15,130,765 | $0 | 3,430,377 (Direct) |
View |
| 2021-04-09 Conversion |
2021-04-13 5:54 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | RiverVest Venture Fund III L.P. RiverVest Venture Fund III (Ohio) L.P. RiverVest Venture Fund IV L.P. 10% Owner |
10,565,705 | $0 | 2,409,220 (Indirect) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:26 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:18 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:16 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | Harrison Kenneth Ph.D. Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:14 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | Seltzer Stacey Denenberg Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:10 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:09 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-04-08 Option Award |
2021-04-12 3:08 pm |
N/A 2031-04-07 |
Reneo Pharmaceuticals Inc. | RPHM | Cardon Lon Director |
14,000 | $0 | 14,000 (Direct) |
View |
Ownership |
2021-04-08 5:57 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner |
0 | $0 | 2,763,711 (Direct) |
View |
Ownership |
2021-04-08 5:40 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Florence Anthony A. Jr. Makhzoumi Mohamad MAKOWER JOSHUA SANDELL SCOTT D Sonsini Peter W. 10% Owner |
0 | $0 | 4,118,828 (Direct) |
View |
Ownership |
2021-04-08 5:37 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | RiverVest Venture Fund III L.P. RiverVest Venture Fund III (Ohio) L.P. RiverVest Venture Fund IV L.P. 10% Owner |
0 | $0 | 2,209,220 (Indirect) |
View |
Ownership |
2021-04-08 5:09 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director |
0 | $0 | 1,980,684 (Indirect) |
View |
Ownership |
2021-04-08 5:03 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director |
0 | $0 | 1,658,226 (Indirect) |
View |
Ownership |
2021-04-08 5:02 pm |
2017-09-01 2028-04-04 |
Reneo Pharmaceuticals Inc. | RPHM | Johnson Wendy S. Chief Development Officer |
0 | $0 | 257,440 (Direct) |
View |
Ownership |
2021-04-08 5:00 pm |
2021-03-16 2031-03-15 |
Reneo Pharmaceuticals Inc. | RPHM | Jindal Vineet R. Chief Financial Officer |
0 | $0 | 234,158 (Direct) |
View |
Ownership |
2021-04-08 4:59 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman |
0 | $0 | 829,219 (Indirect) |
View |
Ownership |
2021-04-08 4:58 pm |
2020-11-02 2031-01-20 |
Reneo Pharmaceuticals Inc. | RPHM | FLESHER GREGORY J. President and CEO |
0 | $0 | 1,052,647 (Direct) |
View |
Ownership |
2021-04-08 4:57 pm |
2021-03-12 2031-03-11 |
Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director |
0 | $0 | 44,694 (Direct) |
View |
Ownership |
2021-04-08 4:56 pm |
N/A N/A |
Reneo Pharmaceuticals Inc. | RPHM | Dorenbaum Alejandro Chief Medical Officer |
0 | $0 | 179,064 (Direct) |
View |
Ownership |
2021-04-08 4:54 pm |
2020-12-02 2031-01-20 |
Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Senior VP, Corporate Operation |
0 | $0 | 229,477 (Direct) |
View |
Ownership |
2021-04-08 4:53 pm |
2019-01-30 2029-01-29 |
Reneo Pharmaceuticals Inc. | RPHM | Cardon Lon Director |
0 | $0 | 46,928 (Direct) |
View |